Paul J Clancy

Paul J Clancy has an estimated net worth of $55.7 Million. This is based on reported shares across multiple companies, which include BIOGEN INC., INCYTE CORP, AGIOS PHARMACEUTICALS, INC., EXACT SCIENCES CORP, Xilio Therapeutics, Inc., ALEXION PHARMACEUTICALS, INC., and Sionna Therapeutics, Inc..

2021 was Paul J Clancy's most active year for acquiring shares with 13 total transactions. Paul J Clancy's most active month to acquire stocks was the month of January. 2013 was Paul J Clancy's most active year for disposing of shares, totalling 39 transactions. Paul J Clancy's most active month to dispose stocks was the month of January. 2013 saw Paul J Clancy paying a total of $6,886,770.25 for 172,282 shares, this is the most they've acquired in one year. In 2013 Paul J Clancy cashed out on 292,057 shares for a total of $36,182,871.47, their largest year based on trade value.